Revised SPC: Decapeptyl™ (triptorelin) SR 3mg/11.25mg/22.5mg
Glenmark Pharmaceuticals Europe Ltd
21 May 2014
?Section 4.2 now states that in patients treated with GnRH analogues for metastatic prostate cancer, treatment is usually continued upon development of castrate-resistant prostate cancer. Reference should be made to relevant guidelines.